Osvaldo Vega-Martínez, Eng., M.S. has served as our Chief Science Officer since joining Speratum Biopharma. He is also the co-inventor of Speratum’s breakthrough technologies. With over eight years of experience managing translational biotechnology research, he has been instrumental in advancing our innovative oncology platforms. Prior